Search for: "Novartis AG"
Results 81 - 100
of 440
Sort by Relevance
|
Sort by Date
1 Jun 2020, 8:02 am
Pacific REGISTER HERE Join Seyfarth attorneys Dean Fanelli, Dawn Mertineit, and Kate Perrelli, along with in-house counsel Julie McCarthy, General Counsel and Vice-President of Legal Genomics Institute of the Novartis Research Foundation, for a webinar about defining and protecting trade secrets in the pharmaceutical industry. [read post]
22 Mar 2020, 5:42 am
The Delhi High Court passed an order in Novartis Ag & Anr v. [read post]
4 Mar 2020, 1:56 pm
Most of the cases have started after patients’ first or second injection of the wet age-related macular degeneration (AMD) drug, Novartis said. [read post]
27 Feb 2020, 12:40 pm
Beovu injections were approved by the FDA in October 2019 to treat wet age-related macular degeneration, a condition that can eventually lead to blindness. [read post]
13 Feb 2020, 8:16 am
Bloomberg reports that Novartis AG, a Swiss Pharmaceutical firm with a Market Capitalization in excess of 220 billion USD and U.S. headquarters in Boston, is... [read post]
23 Jan 2020, 12:55 pm
Already in the Abraxis (C-443/17) case, AG Mr. [read post]
31 Dec 2019, 3:58 am
In one case, Novartis AG, a Swiss pharmaceutical company, developed “Glivec”, an anti-cancer drug. [read post]
7 Nov 2019, 8:10 pm
., 37%; Novo Nordisk AS, 17%; Novartis AG, 14%; and Merck KGa, 13%; Hoffmann-La Roche, 12.7%). [read post]
16 Sep 2019, 9:19 am
” In Novartis AG v. [read post]
3 Jul 2019, 11:02 am
Barbara Levi Mager is a longtime in-house leader for Swiss pharmaceutical company Novartis International AG and Sandoz, a division of Novartis. [read post]
22 Jun 2019, 9:15 am
The landmark judgment of the Supreme Court of India in Novartis AG & Ors. .v. [read post]
22 Jun 2019, 9:15 am
The landmark judgment of the Supreme Court of India in Novartis AG & Ors. .v. [read post]
30 Apr 2019, 7:22 am
Final panellist Jürgen Dressel (ex- Novartis Pharma AG) explained that, going back to basics, the SPC is meant to be a reward for R&D and there should be legal certainty and a harmonised situation for the international market. [read post]
30 Apr 2019, 5:29 am
Jürgen Dressel (ex- Novartis Pharma AG) further commented that of course there is the further issue in Germany that invalidity proceedings cannot even be commenced whilst EPO opposition proceeding are ongoing. [read post]
28 Apr 2019, 8:20 am
In the Rituximab case (District Court of Munich, May 2017), the court said that the generic case law stipulating that the balance of interests in principle favors the originator cannot be applied to biosimilar situations and that a full assessment of the specific circumstances is required in each case.From the audience Jürgen Dressel (ex-Novartis Pharma AG, Basel) asked about the uptake of biosimilars and whether costs will decrease the more medicines healthcare systems… [read post]
13 Apr 2019, 12:25 pm
AG Szpunar thinks not necessarily | The CNY 260 million fine on QVOD is final! [read post]
6 Apr 2019, 9:46 am
AG Szpunar thinks not necessarily | The CNY 260 million fine on QVOD is final! [read post]
2 Apr 2019, 7:39 am
In an email to Reuters, Novartis AG spokesman Eric Althoff said “We are disappointed in today’s decision and look forward to presenting our case at trial. [read post]
27 Mar 2019, 11:33 am
AG Szpunar thinks not necessarily | The CNY 260 million fine on QVOD is final! [read post]
24 Mar 2019, 3:26 pm
AG Szpunar thinks not necessarily | The CNY 260 million fine on QVOD is final! [read post]
